Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lafont

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Annales Pharmaceutiques Francaises|January 1, 1989
[Synthesis of potential metabolites of a barbiturate containing two branched side chains]A Talab, C Cavé, S Ménager, et al.
Journal of Chromatography|March 20, 1987
[Determination of plasma ethambutol with liquid chromatography and ultraviolet spectrophotometry]C Lacroix, F Cerutti, J Nouveau, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1988
Passage of allophanoyl-gamma-lactones through the kidneyO Lafont, C Cave, S Menager, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 15, 2004
Aminoglutethimide included in nanocapsules suspension: comparison of GC-MS and HPLC methods for controlM Berrabah, D Andre, P Verite, et al.
Die Pharmazie|May 8, 2000
Preparation and evaluation of benzyl benzoate-loaded poly-epsilon-caprolactone nanoparticlesM Berrabah, D Andre, P Verite, et al.
International Journal of Pharmaceutics|December 3, 1999
Primidone-loaded poly-epsilon-caprolactone nanocapsules: incorporation efficiency and in vitro release profilesV Ferranti, H Marchais, C Chabenat, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 1994
GC-MS determination of phenobarbitone entrapped in poly-epsilon-caprolactone nanocapsulesM Berrabah, D André, F Prévot, et al.
Annales Pharmaceutiques Francaises|January 1, 1982
[Iminobarbiturates: chemical displacements in d6-DMSO of double-bonded carbon atoms]D Simon, O Lafont, J Mahuteau, et al.
Annales Pharmaceutiques Francaises|August 18, 2004
[Porphyrin catalysts: a tool for preparation of metabolite models]F Estour, B Akagah, J Ségrestaa, et al.
Arzneimittel-Forschung|January 1, 1990
Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiencyC Lacroix, J L Tranvouez, T Phan Hoang, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Annales Pharmaceutiques Francaises|January 1, 1989
[Synthesis of potential metabolites of a barbiturate containing two branched side chains]A Talab, C Cavé, S Ménager, et al.
Journal of Chromatography|March 20, 1987
[Determination of plasma ethambutol with liquid chromatography and ultraviolet spectrophotometry]C Lacroix, F Cerutti, J Nouveau, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1988
Passage of allophanoyl-gamma-lactones through the kidneyO Lafont, C Cave, S Menager, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 15, 2004
Aminoglutethimide included in nanocapsules suspension: comparison of GC-MS and HPLC methods for controlM Berrabah, D Andre, P Verite, et al.
Die Pharmazie|May 8, 2000
Preparation and evaluation of benzyl benzoate-loaded poly-epsilon-caprolactone nanoparticlesM Berrabah, D Andre, P Verite, et al.
International Journal of Pharmaceutics|December 3, 1999
Primidone-loaded poly-epsilon-caprolactone nanocapsules: incorporation efficiency and in vitro release profilesV Ferranti, H Marchais, C Chabenat, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 1994
GC-MS determination of phenobarbitone entrapped in poly-epsilon-caprolactone nanocapsulesM Berrabah, D André, F Prévot, et al.
Annales Pharmaceutiques Francaises|January 1, 1982
[Iminobarbiturates: chemical displacements in d6-DMSO of double-bonded carbon atoms]D Simon, O Lafont, J Mahuteau, et al.
Annales Pharmaceutiques Francaises|August 18, 2004
[Porphyrin catalysts: a tool for preparation of metabolite models]F Estour, B Akagah, J Ségrestaa, et al.
Arzneimittel-Forschung|January 1, 1990
Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiencyC Lacroix, J L Tranvouez, T Phan Hoang, et al.
Pageof 7